For research and educational purposes only. Not medical advice.
GHRP-1 Reference
Educational, not medical advice reference for GHRP-1: GH Release; regulatory status, evidence posture, source review, and schedule notes. Also known as Growt…
Reference summary
Published literature on GHRP-1 is limited to older preclinical and small-human GH-response studies. There is no modern PK/PD or outcome program comparable to GHRP-2, GHRP-6, or ipamorelin.
- Categories
- GH Release
- Aliases
- Growth hormone releasing peptide 1, SKF-108,922
- Evidence posture
- preclinical — Older preclinical and small-human GH-response data only. Less characterized than GHRP-2, GHRP-6, or ipamorelin.
- Regulatory status
- No FDA-approved GHRP-1 drug label. FDA lists GHRP-class peptides among bulk drug substances with safety-risk concerns for compounding. GHRP-1 is less characterized than GHRP-2 or GHRP-6 and is rarely studied in modern literature.
- Content review status
- research reference